$322.0 Million
Immunovant
Immunovant, Inc.
Follow-On Offering
PIPE
Active Bookrunner
$258.7 Million
Cymabay
CymaBay Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$350.0 Million
Crinetics
Crinetics Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$258.7 Million
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$63.2 Million
ALX
ALX Oncology
Confidentially Marketed Follow-On Offering
Active Bookrunner
$138.0 Million
Arhaus
Arhaus, LLC
Follow-On Offering
Active Bookrunner
$60.0 Million
Inozyme
Inozyme Pharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$149.9 Million
Procept
Procept Biorobotics Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$85.0 Million
Sagimet
Sagimet Biosciences
Initial Public Offering
Active Bookrunner
$80.0 Million
Turnstone
Turnstone Biologics Inc.
Initial Public Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.